Related references
Note: Only part of the references are listed.Maintaining confidentiality of interim data to enhance trial integrity and credibility
Thomas R. Fleming et al.
CLINICAL TRIALS (2008)
Frequentist evaluation of group sequential clinical trial designs
Scott S. Emerson et al.
STATISTICS IN MEDICINE (2007)
Biomarker-adaptive threshold design: A procedure for evaluating treatment with possible biomarker-defined subset effect
Wenyu Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Issues in the use of adaptive clinical trial designs
Scott S. Emerson
STATISTICS IN MEDICINE (2006)
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim:: General concepts
Frank Bretz et al.
BIOMETRICAL JOURNAL (2006)
Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients
B Freidlin et al.
CLINICAL CANCER RESEARCH (2005)
Bayesian statistics and the efficiency and ethics of clinical trials
DA Berry
STATISTICAL SCIENCE (2004)
On the inefficiency of the adaptive design for monitoring clinical trials
AA Tsiatis et al.
BIOMETRIKA (2003)
Seamlessly expanding a randomized phase II trial to phase III
LYT Inoue et al.
BIOMETRICS (2002)
Adaptive group sequential designs for clinical trials:: Combining the advantages of adaptive and of classical group sequential approaches
HH Müller et al.
BIOMETRICS (2001)